Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the company has nominated ISM4312A as a preclinical ...
SEOUL, South Korea, Sept. 22, 2025 /PRNewswire/ -- Galux, a South Korea–based biotech company pioneering AI-driven protein therapeutics design, today announced new results that further validate its de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback